With a strong dedication to innovation in the field of Drug Discovery, Diagnostics, MedTech, and other Life Science sectors, i&i Prague supports the creation of spin-off companies and the sale of licenses. Driven by the mission to scout and support the growth of the most promising projects with innovative potential, i&i Prague specializes in discovery, pre-seed, and seed phases. Their objective is to become a leading partner in advancing and promoting game-changing biotech inventions originating from the Central Europe region.

Operating under the Czech Academy of Sciences and its Institute of Organic Chemistry and Biochemistry (IOCB), i&i Prague benefits from extensive expertise and experience gathered from academia and industrial companies. Their team is focused on developing a pool of highly promising biotech projects and finding suitable commercial partners for them. By building upon the legacy of successful anti-HIV drugs invented by Dr.

Antonín Holý, i&i Prague aims to make the world a better place and help millions of people. With their combined expertise and collaborative approach, they are poised to drive innovation and create significant impact in the field of life sciences